It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Spatially resolved transcriptomics has revolutionized RNA studies by aligning RNA abundance with tissue structure, enabling direct comparisons between histology and gene expression. Traditional approaches to identifying signature genes often involve preliminary data grouping, which can overlook subtle expression patterns in complex tissues. We present Spatial Gradient Screening, an algorithm which facilitates the supervised detection of histology-associated gene expression patterns without prior data grouping. Utilizing spatial transcriptomic data along with single-cell deconvolution from injured mouse cortex, and TCR-seq data from brain tumors, we compare our methodology to standard differential gene expression analysis. Our findings illustrate both the advantages and limitations of cluster-free detection of gene expression, offering more profound insights into the spatial architecture of transcriptomes. The algorithm is embedded in SPATA2, an open-source framework written in R, which provides a comprehensive set of tools for investigating gene expression within tissue.
Traditional approaches in spatial transcriptomics often rely on preliminary data grouping, which can overlook subtle expression patterns in tissues. Here, the authors present Spatial Gradient Screening, a tool which facilitates the detection of histology-associated gene expression patterns without prior data grouping.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Kada-Benotmane, Jasim 3
; Koupourtidou, Christina 4
; Ninkovic, Jovica 4 ; Dichgans, Martin 5 ; Beck, Juergen 6
; Schnell, Oliver 7 ; Heiland, Dieter Henrik 8
1 Freiburg University, Microenvironment and Immunology Research Laboratory, Medical Center, Faculty of Medicine, Freiburg, Germany (GRID:grid.5963.9) (ISNI:0000 0004 0491 7203); Erlangen University, Department of Neurosurgery, Medical Center, Faculty of Medicine, Erlangen, Germany (GRID:grid.5330.5) (ISNI:0000 0001 2107 3311)
2 University Hospital, LMU Munich, Institute for Stroke and Dementia Research (ISD), Munich, Germany (GRID:grid.411095.8) (ISNI:0000 0004 0477 2585); LMU Munich, Graduate School of Systemic Neurosciences, Munich, Germany (GRID:grid.5252.0) (ISNI:0000 0004 1936 973X)
3 Freiburg University, Microenvironment and Immunology Research Laboratory, Medical Center, Faculty of Medicine, Freiburg, Germany (GRID:grid.5963.9) (ISNI:0000 0004 0491 7203); Freiburg University, Department of Neurosurgery, Medical Center, Faculty of Medicine, Freiburg, Germany (GRID:grid.5963.9) (ISNI:0000 0004 0491 7203)
4 LMU Munich, Department of Cell Biology and Anatomy, Biomedical Center (BMC), Munich, Germany (GRID:grid.5252.0) (ISNI:0000 0004 1936 973X); Munich Cluster for Systems Neurology (SyNergy), Munich, Germany (GRID:grid.452617.3)
5 University Hospital, LMU Munich, Institute for Stroke and Dementia Research (ISD), Munich, Germany (GRID:grid.411095.8) (ISNI:0000 0004 0477 2585); Munich Cluster for Systems Neurology (SyNergy), Munich, Germany (GRID:grid.452617.3); German Center for Neurodegenerative Diseases (DZNE), Munich, Germany (GRID:grid.424247.3) (ISNI:0000 0004 0438 0426)
6 Freiburg University, Department of Neurosurgery, Medical Center, Faculty of Medicine, Freiburg, Germany (GRID:grid.5963.9) (ISNI:0000 0004 0491 7203)
7 Erlangen University, Department of Neurosurgery, Medical Center, Faculty of Medicine, Erlangen, Germany (GRID:grid.5330.5) (ISNI:0000 0001 2107 3311)
8 Freiburg University, Microenvironment and Immunology Research Laboratory, Medical Center, Faculty of Medicine, Freiburg, Germany (GRID:grid.5963.9) (ISNI:0000 0004 0491 7203); Erlangen University, Department of Neurosurgery, Medical Center, Faculty of Medicine, Erlangen, Germany (GRID:grid.5330.5) (ISNI:0000 0001 2107 3311); University of Freiburg, Comprehensive Cancer Center Freiburg (CCCF), Medical Center, Freiburg, Germany (GRID:grid.5963.9) (ISNI:0000 0004 0491 7203); German Cancer Consortium (DKTK) partner site Freiburg, Freiburg, Germany (GRID:grid.7497.d) (ISNI:0000 0004 0492 0584); Northwestern University, Department of Neurological Surgery, Lou and Jean Malnati Brain Tumor Institute, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Chicago, USA (GRID:grid.16753.36) (ISNI:0000 0001 2299 3507)




